Estrella Biopharma

About:

Estrella Biopharma develops transformative cancer medicines with CD19-Redirected ARTEMIS T Cells to improve patients’ lives.

Website: https://www.estrellabio.com/

Description:

Estrella Biopharma is a biotech firm that is dedicated to advancing cancer treatment with CD19-Redirected ARTEMIS T Cells, aiming to enhance patient outcomes. Leveraging recent breakthroughs in cell therapy, the company focuses on developing transformative medicines not only for hematological malignancies but also for solid tumors. Estrella Biopharma stands at the forefront of pioneering next-generation T-cell therapies, addressing treatment challenges across a spectrum of cancers.

Total Funding Amount:

$10M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Emeryville, California, United States

Founded Date:

2022-01-01

Founders:

Number of Employees:

11-50

Last Funding Date:

2023-09-29

IPO Status:

Public

Industries:

© 2025 bioDAO.ai